These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24913497)

  • 1. Secretory phospholipase A2-IIa upregulates HER/HER2-elicited signaling in lung cancer cells.
    Dong Z; Meller J; Succop P; Wang J; Wikenheiser-Brokamp K; Starnes S; Lu S
    Int J Oncol; 2014 Sep; 45(3):978-84. PubMed ID: 24913497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer.
    Oleksowicz L; Liu Y; Bracken RB; Gaitonde K; Burke B; Succop P; Levin L; Dong Z; Lu S
    Prostate; 2012 Jul; 72(10):1140-9. PubMed ID: 22127954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of secretory phospholipase A2-IIa supports cancer stem cell phenotype via HER/ERBB-elicited signaling in lung and prostate cancer cells.
    Lu S; Dong Z
    Int J Oncol; 2017 Jun; 50(6):2113-2122. PubMed ID: 28440478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer.
    Dong Z; Liu Y; Scott KF; Levin L; Gaitonde K; Bracken RB; Burke B; Zhai QJ; Wang J; Oleksowicz L; Lu S
    Carcinogenesis; 2010 Nov; 31(11):1948-55. PubMed ID: 20837598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group IIa secretory phospholipase A2 (sPLA2IIa) and progression in patients with lung cancer.
    Wang M; Hao FY; Wang JG; Xiao W
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2648-54. PubMed ID: 25317799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of secretory phospholipase A2 IIa reduces lung cancer growth in vitro and in vivo.
    Yu JA; Mauchley D; Li H; Meng X; Nemenoff RA; Fullerton DA; Weyant MJ
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1185-91. PubMed ID: 23079010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretory Phospholipase A2 IIa Mediates Expression of Growth Factor Receptors in Esophageal Adenocarcinoma.
    Halpern AL; Kohtz PD; White AM; Houk AK; Rehring JF; Hanson L; McCarter MD; Joshi M; Meng X; Fullerton DA; Weyant MJ
    Dig Dis Sci; 2021 Mar; 66(3):784-795. PubMed ID: 32277371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vav3 oncogene is involved in regulation of secretory phospholipase A2-IIa expression in prostate cancer.
    Dong Z; Liu Y; Levin L; Oleksowicz L; Wang J; Lu S
    Oncol Rep; 2011 Jun; 25(6):1511-6. PubMed ID: 21455584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules.
    Kupert E; Anderson M; Liu Y; Succop P; Levin L; Wang J; Wikenheiser-brokamp K; Chen P; Pinney SM; Macdonald T; Dong Z; Starnes S; Lu S
    BMC Cancer; 2011 Dec; 11():513. PubMed ID: 22151235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMPK Signaling Involvement for the Repression of the IL-1β-Induced Group IIA Secretory Phospholipase A2 Expression in VSMCs.
    El Hadri K; Denoyelle C; Ravaux L; Viollet B; Foretz M; Friguet B; Rouis M; Raymondjean M
    PLoS One; 2015; 10(7):e0132498. PubMed ID: 26162096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces integrin activation through direct binding to a newly identified binding site (site 2) in integrins αvβ3, α4β1, and α5β1.
    Fujita M; Zhu K; Fujita CK; Zhao M; Lam KS; Kurth MJ; Takada YK; Takada Y
    J Biol Chem; 2015 Jan; 290(1):259-71. PubMed ID: 25398877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group IIa sPLA2 inhibition attenuates NF-κB activity and promotes apoptosis of lung cancer cells.
    Yu JA; Kalatardi S; Dohse J; Sadaria MR; Meng X; Fullerton DA; Weyant MJ
    Anticancer Res; 2012 Sep; 32(9):3601-7. PubMed ID: 22993297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-inflammatory secretory phospholipase A2 type IIA binds to integrins alphavbeta3 and alpha4beta1 and induces proliferation of monocytic cells in an integrin-dependent manner.
    Saegusa J; Akakura N; Wu CY; Hoogland C; Ma Z; Lam KS; Liu FT; Takada YK; Takada Y
    J Biol Chem; 2008 Sep; 283(38):26107-15. PubMed ID: 18635536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secreted Phospholipase A2 Type IIA (sPLA2-IIA) Activates Integrins in an Allosteric Manner.
    Takada Y; Fujita M
    Adv Exp Med Biol; 2017; 925():103-115. PubMed ID: 27864802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. sPLA2-IIA Augments Oxidized LDL-Induced MCP-1 Expression in Vitro Through Activation of Akt.
    Guo Y; Li B; Xu X; Wu R; Li W
    Cell Physiol Biochem; 2015; 37(4):1345-54. PubMed ID: 26488172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Search of factors that intermediate cytokine-induced group IIA phospholipase A2 expression through the cytosolic phospholipase A2- and 12/15-lipoxygenase-dependent pathway.
    Kuwata H; Nonaka T; Murakami M; Kudo I
    J Biol Chem; 2005 Jul; 280(27):25830-9. PubMed ID: 15878884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group IIa secretory phospholipase expression correlates with group IIa secretory phospholipase inhibition-mediated cell death in K-ras mutant lung cancer cells.
    Yu JA; Li H; Meng X; Fullerton DA; Nemenoff RA; Mitchell JD; Weyant MJ
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1479-85. PubMed ID: 23026567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secreted phospholipase A2-IIA-induced a phenotype of activated microglia in BV-2 cells requires epidermal growth factor receptor transactivation and proHB-EGF shedding.
    Martín R; Cordova C; Nieto ML
    J Neuroinflammation; 2012 Jul; 9():154. PubMed ID: 22747893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Concise Update on the Relevance of Secretory Phospholipase A2 Group IIA and its Inhibitors with Cancer.
    Chen J; Ye L; Sun Y; Takada Y
    Med Chem; 2017; 13(7):606-615. PubMed ID: 28185537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory phospholipase A
    Chovatiya GL; Sarate RM; Sunkara RR; Gawas NP; Kala V; Waghmare SK
    Sci Rep; 2017 Sep; 7(1):11619. PubMed ID: 28912581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.